Revenue by source
Neuromodulation Segment$592.81MCardiopulmonary Segment$785.39MCardiac Surgery$0.00Cardiovascular Segment$0.00Neuromodulation$0.00Cardiac Rhythm Management$0.00Advanced Circulatory Support Segment$0.00
| Segment | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Neuromodulation Segment | - | - | $424.55M | $354.44M | $456.17M | $476.99M | $519.71M | $554.22M | $592.81M |
| Cardiopulmonary Segment | - | - | - | - | $482.98M | $500.31M | $588.98M | $683.51M | $785.39M |
| Cardiac Surgery | $611.72M | $681.83M | - | - | - | - | - | - | - |
| Cardiovascular Segment | - | - | $656.65M | $577.08M | - | - | - | - | - |
| Neuromodulation | $351.41M | $422.99M | - | - | - | - | - | - | - |
| Cardiac Rhythm Management | $249.07M | - | - | - | - | - | - | - | - |
| Advanced Circulatory Support Segment | - | - | - | - | $55.46M | $39.30M | $40.32M | - | - |
Revenue by country
UNITED STATES$739.57MEurope$269.18MLocations Excluding The United States And Europe$379.30MNon-U.S. and Europe$0.00Rest Of World$0.00
| Segment | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| UNITED STATES | $490.51M | $494.72M | - | $546.48M | $468.63M | $571.30M | $571.56M | $635.04M | $695.08M | $739.57M |
| Europe | $402.07M | $210.47M | - | $223.18M | $193.37M | $201.53M | $178.80M | $214.79M | $220.03M | $269.18M |
| Locations Excluding The United States And Europe | - | - | - | - | $272.24M | $262.54M | $271.45M | $303.71M | $338.32M | $379.30M |
| Non-U.S. and Europe | $321.35M | $307.08M | - | - | - | - | - | - | - | - |
| Rest Of World | - | - | $2.15M | $314.50M | - | - | - | - | - | - |